Peptide Vaccination in Combination With Azacitidine for Patients With MDS and AML

Clinical trial NCT02750995 · COMPLETED

Trial details

NCT number: NCT02750995
Sponsor: Daniel El Fassi
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Myelodysplastic Syndrome Acute Myeloid Leukemia

Start date: 2016-04-01
Primary completion: 2018-01-02
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.